Document is current
Any future updates will be listed below
-
Authors
Eberle, Julia
Salem, Ahmed https://orcid.org/0000-0002-5115-1779
Hofmann, Mara
Reisser, Anja
Ruiz-Blanco, Yasser B.
Almeida-Hernandez, Yasser https://orcid.org/0000-0001-9832-3534
Gole, Boris
Rall-Scharpf, Melanie https://orcid.org/0000-0003-2991-5223
Angulo-Capel, Jessica https://orcid.org/0000-0001-9661-2148
Monecke, Thomas https://orcid.org/0000-0003-3748-710X
Sanchez-Garcia, Elsa https://orcid.org/0000-0002-9211-5803
Gebhardt, J. Christof M. https://orcid.org/0000-0003-1900-600X
Wiesmüller, Lisa https://orcid.org/0000-0002-2397-5041
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (316249678)
Deutsche Forschungsgemeinschaft (450627322)
Deutsche Forschungsgemeinschaft (450627322)
Deutsche Forschungsgemeinschaft (316249678)
Deutsche Forschungsgemeinschaft (424228829)
Deutsche Forschungsgemeinschaft (EXC 2033 – 390677874 – RESOLV)
Deutsche Forschungsgemeinschaft (316249678)
Deutsche Forschungsgemeinschaft (450627322)
International Graduate School of Molecular Medicine of the Medical Faculty of Ulm University
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 30 March 2026
First Online: 17 April 2026
Competing interests
: The authors Lisa Wiesmüller, Boris Gole, Julia Eberle (née Wille), J. Christof M. Gebhardt, Anja Reisser (née Palmer), Yasser Bruno Ruiz-Blanco, Elsa Sanchez-Garcia are the inventors of the patent with application number PCT/EP2023/051816; applicant: Ulm University, Germany; status of application: Filed international on January 25, 2023; specific aspect of manuscript covered in patent application: Identification of peptide derived from human Ku80 for use in the prevention of genomic rearrangements causing therapy-related leukemia. The remaining authors declare no competing interests.
